More Options for Prelabor Rupture of Membranes, A Bayesian Analysis

TL;DR

This paper uses a Bayesian model to analyze the effectiveness and safety of Pitocin and misoprostol for PROM patients, revealing they are equally effective and safe, thus expanding clinical options.

Contribution

It introduces a Bayesian approach to account for confounding factors like Bishop scores in labor induction research, providing clearer evidence on drug efficacy.

Findings

Pitocin and misoprostol are equally effective and safe for PROM.

Bayesian modeling separates confounding variables from true effects.

Results support broader clinical use of both drugs, especially in resource-limited settings.

Abstract

An obstetric goal for a laboring mother is to achieve a vaginal delivery as it reduces the risks inherent in major abdominal surgery (i.e., a Cesarean section). Various medical interventions may be used by a physician to increase the likelihood of this occurring while minimizing maternal and fetal morbidity. However, patients with prelabor rupture of membranes (PROM) have only two commonly used options for cervical ripening, Pitocin and misoprostol. Little research exists on the benefits/risks for these two key drugs for PROM patients. A major limitation with most induction-of-labor related research is the inability to account for differences in \textit{Bishop scores} that are commonly used in obstetrical practice to determine the next induction agent offered to the patient. This creates a confounding factor, which biases the results, but has not been realized in the literature. In this work, we use a Bayesian model of the relationships between the relevant factors, informed by expert physicians, to separate the confounding variable from its actual impact. In doing so, we provide strong evidence that pitocin and buccal misoprostol are equally effective and safe; thus, physicians have more choice in clinical care than previously realized. This is particularly important for developing countries where neither medication may be readily available, and prior guidelines may create an artificial barrier to needed medication.